Corcept Therapeutics Incorporated (CORT)
NASDAQ · Healthcare
Corcept Therapeutics Incorporated Revenue 2009–2025
Corcept Therapeutics Incorporated annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Corcept Therapeutics Incorporated revenue for the quarter ending March 31, 2026 was 164.9 M, a 4.89% increase year-over-year.
- Corcept Therapeutics Incorporated revenue for the twelve months ending March 31, 2026 was 724.2 M, a 17.42% increase year-over-year.
- Corcept Therapeutics Incorporated annual revenue for 2025 was 761.4 M, a 12.79% increase from 2024.
- Corcept Therapeutics Incorporated annual revenue for 2024 was 675.0 M, a 39.94% increase from 2023.
- Corcept Therapeutics Incorporated annual revenue for 2023 was 482.4 M, a 20.04% increase from 2022.
- Corcept Therapeutics Incorporated annual revenue for 2022 was 401.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Corcept Therapeutics Incorporated Revenue — FAQ
Corcept Therapeutics Incorporated (CORT) revenue over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Corcept Therapeutics Incorporated's revenue?
Corcept Therapeutics Incorporated (CORT) reported revenue of $761M for fiscal 2025.
Where can I see CORT's revenue history?
The chart and table above show Corcept Therapeutics Incorporated's revenue by year and by quarter, including the growth rate.